Smiths Medical, Rolls-Royce and GKN Aerospace first to take ready-to-use solution.
PRISYM 360 SaaS Labeling Solution Offers an Instant Validated Platform for COVID-19 Clinical Trials.
With the EU confirming the postponement of EU MDR to May 26th 2021, the medical device industry has time to get its house in order.
Join industry experts from PRISYM ID and GS1 to learn about the new GS1 Clinical Trial barcode standards and the benefits of adopting AI (7240).
PRISYM ID will be exhibiting and hosting a workshop at this year’s American Medical Device Summit on October 28-29, 2019.
PRISYM ID will be exhibiting at the Clinical Trial Supply East Coast 2019 on the 16th and 17th of October, in King of Prussia, booth 16.
Here’s a blog about the new GS1 Standard for Clinical Trials and how we can help you adopt it
PRISYM ID will be attending this years RAPS Regulatory Convergence on September, 22-24 2019 in Philadelphia.
The imminence of Annex VI will have a resounding impact upon the clinical trial industry, adding further complexity to the existing compliance legislation.
Annex VI EU No 536/2014 is a clinical trial regulation which will impose new labeling challenges to the industry.